Anzeige
❌
Mehr »
Login
Montag, 18.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Rekordumsatz im 3. Quartal, bald schon digitaler Marktführer?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A2QR0E | ISIN: US2075231017 | Ticker-Symbol:
NASDAQ
15.11.24
21:55 Uhr
1,070 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR Chart 1 Jahr
5-Tage-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR 5-Tage-Chart

Aktuelle News zur CONNECT BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.09.Connect Biopharma shares hold at Buy after FDA meeting1Investing.com
05.09.Connect Biopharma GAAP EPS of $0.14, revenue of $24.12M beats by $3.12M1Seeking Alpha
CONNECT BIOPHARMA Aktie jetzt für 0€ handeln
05.09.Connect Biopharma Holdings Ltd - 6-K, Report of foreign issuer1 SEC Filings
05.09.Connect Biopharma Holdings Limited: Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update75GlobeNewswire (Europe)Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as PresidentConnect's new management is currently evaluating the...
► Artikel lesen
02.08.Connect Biopharma Holdings Ltd - 6-K, Report of foreign issuer1SEC Filings
01.07.Connect Biopharma Holdings Limited: Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum1GlobeNewswire (USA)
13.06.Connect Biopharma Holdings Limited: Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)121GlobeNewswire (Europe)SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical...
► Artikel lesen
13.06.Connect Biopharma appoints Barry Quart as CEO2Seeking Alpha
12.06.Connect Biopharma Holdings Ltd - 6-K, Report of foreign issuer1SEC Filings
12.06.Connect Biopharma Holdings Limited: Connect Biopharma Announces New Leadership and Chair of the Board of Directors124GlobeNewswire (Europe)Industry leader Barry Quart, Pharm.D. appointed as Chief Executive Officer succeeding Zheng Wei, Ph.D., who will remain on the Board of Directors and serve as an advisor to assist with the transitionExperienced...
► Artikel lesen
22.05.Connect Biopharma Holdings Limited: Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe ...1GlobeNewswire (USA)
16.04.Connect Biopharma Holdings Limited: Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update169GlobeNewswire (Europe)Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe...
► Artikel lesen
12.12.23Pre-market Movers: Jet.AI, Icosavax, Connect Biopharma, IN8bio, ADC Therapeutics768AFX NewsREDWOOD SHORES (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 06.45 A.M. ET).In the Green Jet.AI Inc. (JTAIZ) is up over 145% at $2.94. Icosavax...
► Artikel lesen
12.12.23Connect Biopharma Holdings Limited: Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma228GlobeNewswire (Europe)The global trial met its primary endpoint showing both doses of rademikibart treatment significantly improved lung function at Week 12The significant improvement in lung function was observed as early...
► Artikel lesen
23.11.23Simcere Pharma, Connect Biopharma Enter Into Agreement For Autoimmune Drug Rademikibart560AFX NewsBEIJING (dpa-AFX) - Simcere Pharmaceutical Group Limited said that it entered into an exclusive license and collaboration agreement with Connect Biopharma HongKong Limited in relation to Rademikibart...
► Artikel lesen
22.11.23Pre-market Movers: Mountain Crest Acquisition Corp. IV, Anghami, Guess?, Connect Biopharma, Captivision1.077AFX NewsSAN RAFAEL (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.05 A.M. ET).In the Green Connect Biopharma Holdings Limited (CNTB) is...
► Artikel lesen
21.11.23Connect Biopharma Holdings Limited: Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China409GlobeNewswire (Europe)Simcere has been granted an exclusive right to develop, manufacture, and commercialize rademikibart for all indications in Greater ChinaConnect Biopharma retains rights to develop and commercialize...
► Artikel lesen
21.11.23Connect Biopharma Holdings Limited: Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis234GlobeNewswire (Europe)Clinical response (IGA 0/1 and EASI-75) achieved at Week 16 with rademikibart treatment was maintained through Week 52 with both every two weeks (Q2W) and every four weeks (Q4W) dosing regimens Approximately...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1